NCT07624136 Effects of Kinesio Taping on Thoracolumbar Fascia Flexibility in Patients With Shoulder Injury
| NCT ID | NCT07624136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kübra Sarıoğlu |
| Condition | Subacromial Impingement Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 6 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2026-09-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6 participants in total. It began in 2026-05-20 with a primary completion date of 2026-09-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial is to investigate the acute effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia (TLF) in individuals with Subacromial Impingement Syndrome (SIS). Participants will be randomly allocated into an intervention group and a sham taping control group. The intervention group will receive fascia correction Kinesio Taping applied to the thoracolumbar region, while the control group will receive sham taping without therapeutic effect. Clinical parameters including pain intensity, trunk range of motion, thoracolumbar fascia flexibility, lumbar mobility, and posterior shoulder capsule tightness will be assessed before the intervention and 45 minutes after the application. This study aims to provide evidence regarding the acute clinical effects of thoracolumbar fascia modulation in individuals with Subacromial Impingement Syndrome.
Eligibility Criteria
Inclusion Criteria: * age between 20 and 40 years, * Body Mass Index (BMI) within the normal range (20-24.9 kg/m²), * a chronic (symptoms persisting for \>3 months) SIS diagnosis Exclusion Criteria: * any shoulder pathology other than SIS (e.g., rotator cuff tear, glenohumeral joint problems), * inability to perform 90° shoulder flexion due to joint limitation or pain ≥8 on the VAS, * overweight or obesity (BMI \>25 kg/m²), * previous back surgery, * low back pain within the last six months, scoliosis, radiologically diagnosed kyphosis or thoracolumbar disc herniation, sacroiliac joint problems, restricted pelvic range of motion (anterior-posterior pelvic tilt), and scapular dyskinesia.
Contact & Investigator
KÜBRA SARIOĞLU, PhD
PRINCIPAL INVESTIGATOR
HACETTEPE ÜNİVERSİTESİ ,Anafartalar, Talatpaşa Blv No:47, 06100 Altındağ/Ankara
Frequently Asked Questions
Who can join the NCT07624136 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07624136 currently recruiting?
Yes, NCT07624136 is actively recruiting participants. Contact the research team at ygulbaltaci@gmail.com for enrollment information.
Where is the NCT07624136 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07624136 clinical trial?
NCT07624136 is sponsored by Kübra Sarıoğlu. The principal investigator is KÜBRA SARIOĞLU, PhD at HACETTEPE ÜNİVERSİTESİ ,Anafartalar, Talatpaşa Blv No:47, 06100 Altındağ/Ankara. The trial plans to enroll 6 participants.